(CIDRAP News) – The British biotechnology company Acambis announced yesterday that it has launched the first clinical trial of its vaccine for West Nile virus, called ChimeriVax-West Nile.
The phase 1 trial will involve 60 adult volunteers in Lenexa, Kan., the company said in a news release. The volunteers will receive one of three doses of the West Nile vaccine or a licensed yellow fever vaccine that is being used as a control.
(CIDRAP News) The first US case of Lassa fever since 1989 is a reminder that physicians need to consider exotic diseases when making diagnoses, noted the Oct 1 edition of Morbidity and Mortality Weekly Report (MMWR).
(CIDRAP News) – An unidentified hemorrhagic fever appears to be targeting children younger than 5 in an outbreak in the African country of Angola.
At least 39 people are believed to have died of the suspected hemorrhagic fever syndrome in the northern province of Uige between January and mid-March, the World Health Organization (WHO) announced on Mar 17.
(CIDRAP News) An initial human trial of a West Nile virus (WNV) vaccine has yielded promising results, officials said today.
In the double-blind, randomized trial, all but one of the people who received the vaccine developed antibodies to it, according to an Associated Press (AP) report quoting Dr. Thomas Monath, chief scientist at Acambis, the company that created the vaccine.
(CIDRAP News) – A recent outbreak of the debilitating tropical disease known as chikungunya fever in northern Italy apparently marks the mosquito-borne infection's first foothold in Europe, according to European health authorities.
(CIDRAP News) Uganda is planning to vaccinate about 2.5 million people in its northern regions against yellow fever, following the recent confirmation that the disease is the cause of a 2-month-old outbreak that has killed more than 40 people, according to press reports.